NATIXIS – Alnylam Pharmaceuticals, Inc. Transaction History
NATIXIS portfolio value:
$45.25M
portfolio value
NATIXIS quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2820.71% | 218.29K shares | 44.12M | $200.16 | 226.03K |
| Q2 2022 | share | Increase | +227.09% | 5.37K shares | 743K | $145.85 | 7.73K |
| Q1 2022 | share | Decrease | -97.73% | -101.69K shares | -17.26M | $163.29 | 2.36K |
| Q4 2021 | share | Increase | +1.51% | 1.54K shares | -1.70M | $171.03 | 104.06K |
| Q3 2021 | share | Increase | +1110.06% | 94.04K shares | 17.92M | $188.81 | 102.51K |
| Q2 2021 | share | Increase | +30.12% | 1.96K shares | 517K | $169.52 | 8.47K |
| Q1 2021 | share | Increase | +227.84% | 4.52K shares | 661K | $141.19 | 6.51K |
| Q4 2020 | share | Decrease | -23.67% | -616 shares | -121K | $129.97 | 1.98K |
| Q3 2020 | share | Increase | 0.00% | 2.60K shares | 379K | $145.6 | 2.60K |